138 related articles for article (PubMed ID: 15625056)
21. Value of somatostatin receptor scintigraphy for preoperative localization of carcinoids.
Kisker O; Weinel RJ; Geks J; Zacara F; Joseph K; Rothmund M
World J Surg; 1996 Feb; 20(2):162-7. PubMed ID: 8661812
[TBL] [Abstract][Full Text] [Related]
22. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue.
Dörr U; Räth U; Sautter-Bihl ML; Guzman G; Bach D; Adrian HJ; Bihl H
Eur J Nucl Med; 1993 May; 20(5):431-3. PubMed ID: 8100192
[TBL] [Abstract][Full Text] [Related]
23. The value of bone scintigraphy, bone marrow scintigraphy and fast spin-echo magnetic resonance imaging in staging of patients with malignant solid tumours: a prospective study.
Haubold-Reuter BG; Duewell S; Schilcher BR; Marincek B; von Schulthess GK
Eur J Nucl Med; 1993 Nov; 20(11):1063-9. PubMed ID: 8287874
[TBL] [Abstract][Full Text] [Related]
24. Localization of metastatic gastroenteropancreatic tumours by somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]-octreotide.
Hammond PJ; Arka A; Peters AM; Bloom SR; Gilbey SG
Q J Med; 1994 Feb; 87(2):83-8. PubMed ID: 8153292
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
26. [Incidence and imaging characteristics of skeletal metastases detected by bone scintigraphy in lung cancer patients].
Jauković L; Ajdinović B; Janković Z; Dugonjić S
Vojnosanit Pregl; 2006 Dec; 63(12):1001-5. PubMed ID: 17252703
[TBL] [Abstract][Full Text] [Related]
27. I-123 MIBG imaging of metastatic carcinoid tumor from the rectum.
Watanabe N; Seto H; Ishiki M; Shimizu M; Kageyama M; Wu YW; Nagayoshi T; Kamisaki Y; Kakishita M
Clin Nucl Med; 1995 Apr; 20(4):357-60. PubMed ID: 7788995
[TBL] [Abstract][Full Text] [Related]
28. Somatostatin-receptor scintigraphy of subcutaneous and thyroid metastases from bronchial carcinoid.
Krausz Y; Pfeffer MR; Glaser B; Lafair J
J Nucl Med; 1996 Sep; 37(9):1537-9. PubMed ID: 8790214
[TBL] [Abstract][Full Text] [Related]
29. 99mTc-depreotide scintigraphy of bone lesions in patients with lung cancer.
Mena E; Camacho V; Estorch M; Fuertes J; Flotats A; Carrió I
Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1399-404. PubMed ID: 15221296
[TBL] [Abstract][Full Text] [Related]
30. In-111 octreotide scan in a case of a neuroendocrine tumor of unknown origin.
Fuster D; Navasa M; Pons F; Vidal-Sicart S; Mateos JJ; Lomeña F; Rodes J; Herranz R
Clin Nucl Med; 1999 Dec; 24(12):955-8. PubMed ID: 10595476
[TBL] [Abstract][Full Text] [Related]
31. Octreoscan in patients with bronchial carcinoid tumours.
Granberg D; Sundin A; Janson ET; Oberg K; Skogseid B; Westlin JE
Clin Endocrinol (Oxf); 2003 Dec; 59(6):793-9. PubMed ID: 14974924
[TBL] [Abstract][Full Text] [Related]
32. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
[TBL] [Abstract][Full Text] [Related]
33. High false negative rate of Tc-99m MDP whole-body bone scintigraphy in detecting skeletal metastases for patients with hepatoma.
Chen CY; Wu K; Lin WH; Lan TY; Wang SY; Sun JS; Weng PW; Yen RF; Yang RS
J Formos Med Assoc; 2012 Mar; 111(3):140-6. PubMed ID: 22423667
[TBL] [Abstract][Full Text] [Related]
34. Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management.
Gibril F; Doppman JL; Reynolds JC; Chen CC; Sutliff VE; Yu F; Serrano J; Venzon DJ; Jensen RT
J Clin Oncol; 1998 Mar; 16(3):1040-53. PubMed ID: 9508189
[TBL] [Abstract][Full Text] [Related]
35. High-dose indium 111In pentetreotide radiotherapy for metastatic atypical carcinoid tumor.
Meyers MO; Anthony LB; McCarthy KE; Drouant G; Maloney TJ; Espanan GD; Woltering EA
South Med J; 2000 Aug; 93(8):809-11. PubMed ID: 10963516
[TBL] [Abstract][Full Text] [Related]
36. Whole-body magnetic resonance imaging for detecting bone metastases: comparison with bone scintigraphy.
Cascini G; Falcone C; Greco C; Bertucci B; Cipullo S; Tamburrini O
Radiol Med; 2008 Dec; 113(8):1157-70. PubMed ID: 18958408
[TBL] [Abstract][Full Text] [Related]
37.
Wondergem M; van der Zant FM; Knol RJJ; Burgers AMG; Bos SD; de Jong IJ; Pruim J
World J Urol; 2018 Jan; 36(1):27-34. PubMed ID: 29043431
[TBL] [Abstract][Full Text] [Related]
38. Neuroendocrine tumors and somatostatin: imaging techniques.
de Herder WW; Kwekkeboom DJ; Valkema R; Feelders RA; van Aken MO; Lamberts SW; van der Lely AJ; Krenning EP
J Endocrinol Invest; 2005; 28(11 Suppl International):132-6. PubMed ID: 16625862
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET.
Fujimoto R; Higashi T; Nakamoto Y; Hara T; Lyshchik A; Ishizu K; Kawashima H; Kawase S; Fujita T; Saga T; Togashi K
Ann Nucl Med; 2006 Jul; 20(6):399-408. PubMed ID: 16922468
[TBL] [Abstract][Full Text] [Related]
40. Rectal carcinoid metastatic to the skeleton. Scintigraphic and radiographic correlation.
Jolles PR
Clin Nucl Med; 1994 Feb; 19(2):108-11. PubMed ID: 8187393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]